Bill Restoring FTC Authority To Seek Monetary Recovery Advances In US House
Executive Summary
During subcommittee markup, Republican members offered amendments to limit FTC’s ability to seek monetary relief for consumers. Measure has the ‘potential to be a legacy bill,’ ranking member says, indicating it may clear Congress.
You may also be interested in...
FTC Navigating Regulatory Restraints As Bill To Restore Monetary Relief Authority Faces Challenges
Congressional Republicans and biopharma stakeholders support legislation clarifying the Federal Trade Commission’s authority to assess monetary penalties but argue the House legislation needs guardrails.
US FTC Removing ‘Handcuffs’ To Pursue Pharma Companies, PBMs For Antitrust Violations
Agency staff has more freedom to launch investigations under resolutions approved at Commission’s first meeting under new chair. Mergers and rebate walls expected to be major priorities.
FTC May Be Hampered In Pursuing Actions Against Pharma In Wake Of Supreme Court Ruling
High court’s decision that FTC lacks authority to seek monetary recovery in litigation is boon for drug makers who have been subject to hefty payouts in reverse settlement and other cases brought by the commission.